Fluorescence spectra of cardiac myosin and in vivo experiment: studies on daunorubicin-induced cardiotoxicity

Fluorescence spectra of cardiac myosin and in vivo experiment: studies on daunorubicin-induced cardiotoxicity

Objective(s):The objective of this study was to investigate the interaction of daunorubicin (DNR) and cardiac myosin (CM) and the changes in mice hearts to exhibit DNR-induced cardiotoxicity . Materials and Methods:The interaction between DNR and CM was expressed using fluorescence quenching at pH 4...

Full description

Bibliographic Details
Main Authors:	Yang Liu, Chi Chen, Xiaoxiang Duan, Wenting Ma, Man Wang, Mengyi Tu, Ying Chen
Format:	Article
Language:	English
Published:	Mashhad University of Medical Sciences 2015-12-01
Series:	Iranian Journal of Basic Medical Sciences
Subjects:	Cardiac myosin Cardiotoxicity Daunorubicin Fluorescence quenching Myocardial enzyme
Online Access:	http://ijbms.mums.ac.ir/pdf_6272_66fae3914304e4126c22dfc5f0b1942a.html

Similar Items

Potential effects of pomegranate on lipid peroxidation and pro-inflammatory changes in daunorubicin-induced cardiotoxicity in rats
by: Hayder M Al-Kuraishy, et al.
Published: (2016-01-01)

Anthracycline-Induced Cardiotoxicity
by: Radomír Hrdina, et al.
Published: (2000-01-01)

Carvedilol Attenuates Inflammatory-Mediated Cardiotoxicity in Daunorubicin-Induced Rats
by: Punniyakoti T. Veeravedu, et al.
Published: (2011-03-01)

A discovery study of daunorubicin induced cardiotoxicity in a sample of acute myeloid leukemia patients prioritizes P450 oxidoreductase polymorphisms as potential risk factor.
by: Joanna M Lubieniecka, et al.
Published: (2013-11-01)

Effect of Sodium 2,3-Dimercaptopropane-1-Sulphonate (DMPS) on Chronic Daunorubicin Toxicity in Rabbits: Comparison with Dexrazoxane
by: Radomír Hrdina, et al.
Published: (2002-01-01)

Electrocardiographic characteristics of Nigerian children on anthracycline-based chemotherapy: A preliminary report
by: I D Peter, et al.
Published: (2017-01-01)

A rare cause of bifascicular block: Daunorubicin induced cardiotoxicity
by: Prakas Kumar Mandal, et al.
Published: (2016-01-01)

N-Alkylation of Anthracycline Antibiotics by Natural Sesquiterpene Lactones as a Way to Obtain Antitumor Agents with Reduced Side Effects
by: Margarita Neganova, et al.
Published: (2021-05-01)

Experimental inhibition of proliferative vitreoretinopathy in retinal detachment using daunorubicin
by: Kumar Atul, et al.
Published: (1994-01-01)

Fluorescence labeling and computational analysis of the strut of myosin's 50 kDa cleft.
by: Gawalapu, Ravi Kumar
Published: (2007)

Intrinsic and extrinsic apoptosis responses in leukaemia cells following daunorubicin treatment
by: Hussain Mubarak Al-Aamri, et al.
Published: (2021-04-01)

Nuclear Lipid Microdomains Regulate Daunorubicin Resistance in Hepatoma Cells
by: Michela Codini, et al.
Published: (2018-11-01)

A Pilot Study of Matrix Metalloproteinases on the Model of Daunorubicin-induced Cardiomyopathy in Rabbits
by: Anna Potáčová, et al.
Published: (2007-01-01)

Novel formulation of cytarabine and daunorubicin: A new hope in AML treatment
by: Lalit S Raut
Published: (2015-01-01)

Liposomal daunorubicin and dexamethasone as a treatment for multiple myeloma: the DD Protocol
by: Frederico Luiz Dulley, et al.

Daunorubicin reduces MBNL1 sequestration caused by CUG-repeat expansion and rescues cardiac dysfunctions in a Drosophila model of myotonic dystrophy
by: Mouli Chakraborty, et al.
Published: (2018-04-01)

Quercetin as a Potential Modulator of P-Glycoprotein Expression and Function in Cells of Human Pancreatic Carcinoma Line Resistant to Daunorubicin
by: Piotr Dziegiel, et al.
Published: (2010-02-01)

Applications of daunorubicin-loaded PLGA-PLL-PEG-Tf nanoparticles in hematologic malignancies: an in vitro and in vivo evaluation
by: Bao W, et al.
Published: (2019-04-01)

Daunorubicin induced Stevens‐Johnson syndrome: A case report
by: Preeti Shakya, et al.
Published: (2021-07-01)

Different influence of Arac combined with idarubicin and with daunorubicin on malignant molecule expression of acute myelocytic leukemia
by: Abudourexiti Nuerbiya, et al.
Published: (2018-05-01)

ABT-737, Synergistically Enhances Daunorubicin-Mediated Apoptosis in Acute Myeloid Leukemia Cell Lines
by: Hassan Dariushnejad, et al.
Published: (2014-03-01)

Anti-CD123 antibody-modified niosomes for targeted delivery of daunorubicin against acute myeloid leukemia
by: Fu-rong Liu, et al.
Published: (2017-01-01)

Dexrazoxane for cardioprotection in older adults with acute myeloid leukemia
by: Pankit Vachhani, et al.
Published: (2017-01-01)

CHEMOTHERAPY CARDIOTOXICITY SCREENING WITH CARDIAC TROPONINS
by: O. V. Krikunova, et al.
Published: (2015-12-01)

Olaparib Synergizes the Anticancer Activity of Daunorubicin via Interaction with AKR1C3
by: Tássia S. Tavares, et al.
Published: (2020-10-01)

Troponin-I and left ventricular function in pediatric high-risk acute lymphoblastic leukemia after daunorubicin treatment
by: Rinche Annur, et al.
Published: (2021-03-01)

Reformulating acute myeloid leukemia: liposomal cytarabine and daunorubicin (CPX-351) as an emerging therapy for secondary AML
by: Chen EC, et al.
Published: (2018-06-01)

Effect of daunorubicin drug with and without cimetidine on the nucleated cells of bone marrow of balb/c mouse
by: ali asghar Kiani, et al.
Published: (2004-01-01)

In vitro cytotoxicity of the LDE: daunorubicin complex in acute myelogenous leukemia blast cells
by: P.E. Dorlhiac-Llacer, et al.
Published: (2001-10-01)

The first attempt on fabrication of a nano-biosensing platform and exploiting first-order advantage from impedimetric data: Application to simultaneous biosensing of doxorubicin, daunorubicin and idarubicin
by: Shokoufeh Soleimani, et al.
Published: (2020-08-01)

MiR-15a-5p Confers Chemoresistance in Acute Myeloid Leukemia by Inhibiting Autophagy Induced by Daunorubicin
by: Emeline Bollaert, et al.
Published: (2021-05-01)

Cardiotoxicity Complication of Radiotherapy
by: Beta Agustia Wisman, et al.
Published: (2017-12-01)

Synthesis and in vitro biochemical evaluation of oxime bond-linked daunorubicin–GnRH-III conjugates developed for targeted drug delivery
by: Sabine Schuster, et al.
Published: (2018-04-01)

Melt electrospinning of daunorubicin hydrochloride-loaded poly (ε-caprolactone) fibrous membrane for tumor therapy
by: He Lian, et al.
Published: (2017-06-01)

Carbamazepine Cardiotoxicity
by: J Gordon Millichap
Published: (1993-10-01)

Analysis of Myosin Viii Function in the Moss Physcomitrella Patens
by: Ritchie, Julie
Published: (2009)

Daunorubicin and gambogic acid coloaded cysteamine-CdTe quantum dots minimizing the multidrug resistance of lymphoma in vitro and in vivo
by: Zhou Y, et al.
Published: (2016-10-01)

CPX-351: a nanoscale liposomal co-formulation of daunorubicin and cytarabine with unique biodistribution and tumor cell uptake properties
by: Mayer LD, et al.
Published: (2019-05-01)

Cardiotoxicity of Anticancer Therapeutics
by: Jerry Dong, et al.
Published: (2018-02-01)

Myosin XVI in the Nervous System
by: Elek Telek, et al.
Published: (2020-08-01)